The Uromigos
The UromigosEpisodes
Episodes of The Uromigos
Mark All
Search Episodes...
Alison Birtle describes adjuvant chemotherapy in bladder cancer.
Daniel Goldstein describes his work on this issue.
In this second part, Matt Galsky describes the OS signal data. We also look into the future.
Tom, Brian and Matt Galsky review the screening component of this study, presented at EAU24.
Michiel Van der Heijden explores the role of radiotherapy and other neoadjuvant and other neoadjuvant combinations to prevent the need for surgery.
Matt Galsky describes his phase 2 study looking at gem/cis/nivo followed by nivo in responders. This potentially avoids cystectomy.
FDA Deputy Oncology Director Dan Suzman described approaches to oncology trials. Tom asks 3 last questions which annoys Brian more than usual.
Tanya Dorff describes acapatamab, a prostate-specific membrane antigen (PSMA) CD3 bispecific engager.
Michael Lattanzi discusses treatment plans and research in the community.
Hans Hammers discusses trial design and patient selection in the adjuvant setting.
Vania Wisdom, editor of the Lancet, talks about approaches to cancer treatment and research in developing countries
David McDermott discusses melanoma and renal data. We never get to bladder or lung.
Dana Rathkopf describes phase 1 data for the androgen receptor ligand-directed degrader in prostate cancer
Neeraj Agarwal addresses the issues raised at the meeting.
Cris Bergerot describes her modifications of existing QOL models while Tom describes the QOL data from LS005
Pedro Barata summarises his ASCO GU discussion on this topic.
Andrea Apolo describes the results of this positive trial.
Kim Chi discussed the prostate cancer oral session at ASCO GU 2024.
Misha Beltran describes the activity of this novel agent in neuroendocrine prostate cancer.
Neeraj Agarwal describes the results of this positive randomised Phase 3 trial.
What to look out for in bladder, prostate and renal cancer at this year's meeting.
Karim Fizazi discusses the clinical and biomarker components of this data.
Thomas Zilli discusses controversies around radiotherapy in prostate cancer.
Silke Gillessen and Betrand Tombal discuss the questions which will address this issue in Lugano in March 2024.
Join Podchaser to...
- Rate podcasts and episodes
- Follow podcasts and creators
- Create podcast and episode lists
- & much more
Unlock more with Podchaser Pro
- Audience Insights
- Contact Information
- Demographics
- Charts
- Sponsor History
- and More!
- Account
- Register
- Log In
- Find Friends
- Resources
- Help Center
- Blog
- API
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More
- © 2024 Podchaser, Inc.
- Privacy Policy
- Terms of Service
- Contact Us